4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0001193125-26-043315
Chief Operating Officer sold 18,652 shares at $2.36 ($44,019)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Keutzer Timothy Chief Operating Officer | 2026-02-06 | Sale | −18,652 | $2.36 | $44,019 | 742,506 | D |
| Open-market sales · 18,652 sh · avg $2.36 · $44,019 | |||||||
Loading xslF345X05/ownership.xml…